CK生命科学专利 新的癌症疫苗 显示有希望 抑制肿瘤的生长。 CK Life Sciences patents new cancer vaccines that show promise in inhibiting tumor growth.

CK生命科学已经申请了针对TROP2的新癌症疫苗专利,这种蛋白质在乳腺癌、肺癌和直肠癌等几种癌症中的高浓度中被发现。 CK Life Sciences has filed patents for new cancer vaccines targeting TROP2, a protein found in high levels in several cancers like breast, lung, and colorectal. 对三联阴性乳腺癌的临床预科研究表明,肿瘤生长受到100%的抑制。 Preclinical studies on triple-negative breast cancer showed 100% tumor growth inhibition. 该公司计划在取得有希望的成果后,将这些疫苗转入临床试验,以防止癌症复发。 The company plans to move these vaccines into clinical trials to prevent cancer recurrence, following promising results.